CSIR-NIIST introduces new tech for biomedical waste safety
WATER & WASTE

CSIR-NIIST introduces new tech for biomedical waste safety

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country.

This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26.

As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing.

Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste.

Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, "This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration."

Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source.

However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board.

"CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept," he had added.

Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country. This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26. As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing. Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste. Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration. Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source. However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board. CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept, he had added. Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

Related Stories

Gold Stories

Next Story
Products

Koemmerling opens Navi Mumbai experience centre

Koemmerling, a brand of the profine Group, has expanded its presence in the Mumbai metropolitan region with the opening of a new experience centre in Navi Mumbai and launched its Allure S46 minimal sliding door system for the Indian market.Located in CBD Belapur, the facility was inaugurated by Peter Mrosik, Owner and CEO, profine Group, along with Farid Khan, Chairman and Managing Director, profine India, and Kamal Bajaj, CEO, profine India.The company said the new centre will showcase its portfolio of uPVC and aluminium window and door systems to architects, developers and homeowners.The ina..

Next Story
Products

India's waterproofing market nears Rs 150 bn milestone

India's waterproofing industry is approaching a market size of Rs 150 billion and is expected to surpass the $2 billion milestone, according to speakers at the 2nd India International Waterproofers Conference & Expo 2026 organised by the Waterproofers Association of India (WAI) in New Delhi.The two-day event brought together more than 20 speakers, 55 international delegates and 53 exhibition booths, with discussions focusing on climate-resilient construction, advanced waterproofing technologies and international collaboration.Inaugurating the event, Durga Shanker Mishra, former Secretary, ..

Next Story
Real Estate

Dilip Buildcon Q1 FY27 Revenue at Rs 23.78 billion

Dilip Buildcon Limited reported consolidated revenue from operations of Rs 2,378 crore in Q1 FY27, along with EBITDA of Rs 429 crore and profit after tax of Rs 128 crore.Consolidated EBITDA margin stood at 18.1%, improving from 17.1% in Q4 FY26. On a standalone basis, revenue from operations was Rs 1,930 crore, EBITDA stood at Rs 199 crore and PAT was Rs 39 crore, with an EBITDA margin of 10.3%.The company’s order book stood at Rs 27,691 crore as of 30 June 2026, compared with Rs 28,830 crore as of 31 March 2026. Roads and highways accounted for 17.1% of the order book, irrigation and water ..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement